HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Legge, K. L. Articles by Zaghouani, H. Search for Related Content PubMed PubMed Citation Articles by Legge, K. L. Articles by Zaghouani, H. Pubmed/NCBI databases Substance via MeSH

TCR Agonist and Antagonist Exert In Vivo Cross-Regulation When Presented on Igs¹

Department of Microbiology, University of Tennessee, Knoxville, TN 37996

Ig-PLP1 and Ig-PLP-LR are chimeric Igs expressing proteolipid protein (PLP)-derived T cell agonist (PLP1) and antagonist (PLP-LR) peptides, respectively. Both chimeras, like free PLP1 and PLP-LR peptides, induce in vivo-specific T cell responses. However, the responses induced by Ig-PLP1 and Ig-PLP-LR were cross-reactive with both PLP1 and PLP-LR peptides, while those induced by free peptides were not. Surprisingly, despite the cross-reactivity of the responses, when Ig-PLP1 and Ig-PLP-LR were administered together into mice, a dose-dependent down-regulation of both T cell responses and a reduction of IL-2 production to background levels was observed. In contrast, when T cells induced by either Ig chimera were stimulated in vitro with mixtures of free PLP1 and PLP-LR peptides, there was no down-regulation of proliferation or decrease in IL-2 production. These data indicate that Ig-PLP1 and Ig-PLP-LR exert adverse reactions on one another at the level of naive T cells, resulting in an opposite antagonism. However, naive T cells experiencing either chimera develop into cross-reactive cells, acquire resistance to TCR triggering by closely related but different peptides, and support responsiveness.

This article has been cited by other articles:

				I. B. Rasmussen, E. Lunde, T. E. Michaelsen, B. Bogen, and I. Sandlie The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: Implications for peptide vaccination PNAS, August 17, 2001; (2001) 181336898. [Abstract] [Full Text] [PDF]

				K. L. Legge, B. Min, J. J. Bell, J. C. Caprio, L. Li, R. K. Gregg, and H. Zaghouani Coupling of Peripheral Tolerance to Endogenous Interleukin 10 Promotes Effective Modulation of Myelin-Activated T Cells and Ameliorates Experimental Allergic Encephalomyelitis J. Exp. Med., June 19, 2000; 191(12): 2039 - 2052. [Abstract] [Full Text] [PDF]

				K. L. Legge, B. Min, C. Pack, J. Caprio, and H. Zaghouani Differential Presentation of an Altered Peptide Within Fetal Central and Peripheral Organs Supports an Avidity Model for Thymic T Cell Development and Implies a Peripheral Readjustment for Activation J. Immunol., May 15, 1999; 162(10): 5738 - 5746. [Abstract] [Full Text] [PDF]

				B. Min, K. L. Legge, C. Pack, and H. Zaghouani Neonatal Exposure to a Self-Peptide-Immunoglobulin Chimera Circumvents the Use of Adjuvant and Confers Resistance to Autoimmune Disease by a Novel Mechanism Involving Interleukin 4 Lymph Node Deviation and Interferon {gamma}-mediated Splenic Anergy J. Exp. Med., December 7, 1998; 188(11): 2007 - 2017. [Abstract] [Full Text] [PDF]

				I. B. Rasmussen, E. Lunde, T. E. Michaelsen, B. Bogen, and I. Sandlie The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: Implications for peptide vaccination PNAS, August 28, 2001; 98(18): 10296 - 10301. [Abstract] [Full Text] [PDF]